
Lebra Infusion
Marketer
Suncure Lifescience Pvt Ltd
Salt Composition
Levetiracetam (100mg)
Overview Lebra Infusion
Epileptic seizures are managed with the anticonvulsant Lebra Infusion, administered intravenously as a slow infusion under medical supervision. This treatment is typically short-term, bridging gaps when oral medication is impractical (e.g., unconsciousness). Continued use, as directed by your physician, is crucial for seizure prevention; discontinuation or missed doses risk increased seizure frequency. Following infusion, your doctor will likely prescribe oral medication for long-term management. Common side effects, often diminishing after initial days, include drowsiness, headache, infection, local irritation, nasopharyngitis, reduced appetite, and behavioral changes (aggressiveness, irritability). While most side effects are mild, allergic reactions (hives, itching, weakness, breathing difficulties, facial/tongue/throat swelling), skin rashes, or persistent behavioral changes (confusion, forgetfulness, increased aggression) warrant immediate medical attention. Suicidal ideation has been reported; report any worsening mood to your doctor promptly. Pre-treatment disclosure of kidney disease, depression, suicidal thoughts, or pregnancy is essential. Alcohol should be avoided due to increased seizure risk and exacerbated side effects (drowsiness, dizziness). Drowsiness and dizziness can impair driving and machinery operation. Regular kidney function monitoring may be necessary.
Primary Ingredients of Lebra Infusion
No text was provided to rewrite.
Uses of Lebra Infusion
Managing Epileptic Seizures
Major Benefits of Lebra Infusion:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Lebra Infusion:
- Sleepiness
- Dizziness
- Decreased appetite
- Fatigue
- Headache
- Behavioral changes
- Irritation
- Aggressive behavior
- Agitation
- Infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Lebra Infusion:
This medication will be administered by your healthcare provider. Self-medication is not advised.
How Lebra Infusion works:
Lebra Infusion, an anti-convulsant drug, targets specific receptors (SV2A) located on neuronal membranes. This binding action inhibits aberrant neuronal firing patterns within the brain, thereby preventing the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Lebra Infusion should not be taken with alcohol.
PregnancyCONSULT YOUR DOCTOR
Use of Lebra Infusion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Lebra Infusion without significant risk. Available human data indicates minimal danger to the infant. Observe the infant for drowsiness and satisfactory weight increase.
DrivingUNSAFE
Administering Lebra Infusion can reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Exercise caution when administering Lebra Infusion to individuals with impaired renal function. Dosage modifications for Lebra Infusion may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Lebra Infusion is likely safe for individuals with liver conditions. Current evidence indicates dose modification of Lebra Infusion may be unnecessary for such patients. Physician consultation is recommended. Nevertheless, a reduced dosage might be appropriate for those with advanced liver impairment.
What if you forget to take Lebra Infusion :
Should you forget a Lebra Infusion dose, administer the injection at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed injection and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Lebra Infusion
| Label | Value |
|---|---|
| Chemical Classification | Pyrrolidinone-Acetamide Hybrid |
| Developing Good Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | AED: A protein ligand in synaptic vesicle 2 |
